Relationship between KCNQ1 (LQT1) and KCNH2 (LQT2) gene mutations and sudden death during illegal drug use

[1]  R. Bai,et al.  Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives , 2018, Oncotarget.

[2]  T. Janus,et al.  Fatal Intoxication with α‐PVP, a Synthetic Cathinone Derivative , 2017, Journal of forensic sciences.

[3]  M. Kassiou,et al.  Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination† †The authors declare no competing interests. , 2016, MedChemComm.

[4]  K. S. Yoon,et al.  Synthetic cannabinoid, JWH-030, induces QT prolongation through hERG channel inhibition. , 2016, Toxicology research.

[5]  Farzaneh Ghobadi,et al.  Synthetic Cannabinoids and Their Effects on the Cardiovascular System. , 2016, The Journal of emergency medicine.

[6]  S. Priori,et al.  Congenital Long QT Syndrome Type 3 , 2014 .

[7]  Y. Goda,et al.  Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. , 2014, Drug testing and analysis.

[8]  I. Bitter,et al.  Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary. , 2013, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

[9]  Miya Nunotani,et al.  Molecular analysis of potassium ion channel genes in sudden death cases among patients administered psychotropic drug therapy: are polymorphisms in LQT genes a potential risk factor? , 2013, Journal of Human Genetics.

[10]  L. Graham,et al.  Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives , 2013, Journal of Interventional Cardiac Electrophysiology.

[11]  S. Inokuchi,et al.  SPME–GC–MS analysis of α-pyrrolidinovaleorophenone in blood in a fatal poisoning case , 2013, Forensic Toxicology.

[12]  K. Wada.  The history and current state of drug abuse in Japan , 2011, Annals of the New York Academy of Sciences.

[13]  M. Horie,et al.  Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome , 2009, Circulation. Arrhythmia and electrophysiology.

[14]  Jonathan M. Meyer,et al.  Cardiovascular effects of antipsychotics , 2007, Expert review of neurotherapeutics.

[15]  W. Haning,et al.  Electrocardiographic abnormalities in methamphetamine abusers. , 2007, Addiction.

[16]  K. Kudo,et al.  Methamphetamine-related sudden death with a concentration which was of a 'toxic level'. , 2006, Legal medicine.

[17]  Dan M Roden,et al.  KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome , 2005, Circulation.

[18]  P. C. Viswanathan,et al.  Genetics of acquired long QT syndrome. , 2005, The Journal of clinical investigation.

[19]  G. Breithardt,et al.  Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients , 2004, Journal of Molecular Medicine.

[20]  Michael J Ackerman,et al.  Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. , 2003, Mayo Clinic proceedings.

[21]  T. Seto,et al.  Crystal Methamphetamine‐Associated Cardiomyopathy: Tip of the Iceberg? , 2003, Journal of toxicology. Clinical toxicology.

[22]  H. Huikuri,et al.  Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. , 2002, Journal of the American College of Cardiology.

[23]  M. Horie,et al.  Evidence for a Single Nucleotide Polymorphism in the KCNQ1 Potassium Channel that Underlies Susceptibility to Life‐Threatening Arrhythmias , 2001, Journal of cardiovascular electrophysiology.

[24]  C. Hart,et al.  Effects of repeated oral methamphetamine administration in humans , 2001, Psychopharmacology.

[25]  M. Brecht,et al.  Predictors of Relapse After Treatment for Methamphetamine Use , 2000, Journal of psychoactive drugs.

[26]  S. Priori,et al.  Low penetrance in the long-QT syndrome: clinical impact. , 1999, Circulation.

[27]  Ward Oc.  A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964 .

[28]  G. Gemme,et al.  [RARE CARDIAC ARRYTHMIAS OF THE PEDIATRIC AGE. II. SYNCOPAL ATTACKS DUE TO PAROXYSMAL VENTRICULAR FIBRILLATION. (PRESENTATION OF 1ST CASE IN ITALIAN PEDIATRIC LITERATURE)]. , 1963, La Clinica pediatrica.

[29]  A. Jervell,et al.  Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death , 1957 .

[30]  Y. Goda,et al.  [Prevalence of new designer drugs and their legal status in Japan]. , 2013, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[31]  Ian M. Anderson,et al.  Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death , 2012, Drugs.

[32]  O. C. Ward.  A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964, Journal of the Irish Medical Association.